AI-Powered Smart Glasses Secure £1m Prize to Support Dementia Patients
An innovative AI software designed for integration into smart glasses has been awarded a prestigious £1 million prize for its potential to assist individuals living with dementia. The technology, known as CrossSense, is embedded within chunky, black-rimmed frames equipped with a camera, microphone, and speakers. It features a conversational AI assistant named Wispy, which provides guidance through daily activities using verbal cues and floating text displayed in the wearer's field of vision.
Enhancing Independence Through Advanced Technology
CrossSense not only delivers prompts and feedback during tasks but also engages users in light conversation and aids in reminiscence, aiming to foster greater independence. The software emerged victorious in the Longitude prize on dementia, an award initiative managed by Challenge Works with support from Nesta. This prize, funded by the Alzheimer's Society and Innovate UK, seeks to spur technological advancements that help dementia patients maintain autonomy longer, addressing a global health challenge projected to affect 150 million people by 2050.
Szczepan Orlins, CEO of CrossSense Ltd, highlighted that the prize funds will accelerate the product's market entry. A smartphone version is slated for release by the end of this year, with the smart glasses expected to become available in early 2027. Orlins explained that the company collaborates with various hardware manufacturers to produce frames compatible with prescription lenses and hearing aids. A pilot program is planned for the last quarter of 2026, involving four-week home trials to gather essential data for final refinements.
Practical Applications and User Adaptation
The CrossSense system allows caregivers to input details about the wearer's care needs via an accompanying app. Wispy utilizes machine learning to adapt to individual requirements, including changes in the user's condition over time. Subscription costs are estimated at around £50 per month, with the smart glasses priced up to £1,000, though prices may decrease. Initially marketed directly to consumers, the goal is to eventually make the glasses accessible through the NHS.
Professor Julia Simner from the University of Sussex, who led scientific testing, reported significant improvements in a study involving 23 pairs of dementia patients and carers. Without the glasses, participants correctly identified only 46% of household items, but with CrossSense, accuracy soared to 82%. Notably, this benefit persisted even after removal, with an 78% accuracy rate maintained an hour later.
Expert Insights and Ethical Considerations
Dr. Foyzul Rahman, a cognitive decline expert at Loughborough University, praised CrossSense for offering real-time assistance rather than simple reminders. However, he emphasized the need for larger, controlled studies to validate everyday benefits and raised ethical concerns regarding data consent and usage. Challenges include a limited battery life of one hour, necessitating a portable power bank, and ensuring user adoption.
For users like Carole Greig, 70, diagnosed with Alzheimer's nearly three years ago, the technology represents a breakthrough. She expressed excitement about the potential for increased independence and improved quality of life, stating it allows individuals to cope independently and enjoy daily activities without feeling burdensome.
